Cystatin C in a high-risk combination.
Iwanaga
Yoshitaka
Y
Miyazaki
Shunichi
S
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000401:mortality; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology; D003404:Creatinine / Q000097:blood; D055316:Cystatin C / Q000097:blood*; D005919:Glomerular Filtration Rate; D017052:Hospital Mortality; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000150:complications / Q000401:mortality / Q000628:therapy*; D010359:Patient Readmission; D011237:Predictive Value of Tests; D012372:ROC Curve; D012008:Recurrence; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D015415:Biomarkers; C525030:CST3 protein, human; D055316:Cystatin C; D003404:Creatinine